BrightView Health, a portfolio company of Shore Capital Partners, announced its acquisition of Corebella Health & Wellness on Sept. 7, marking the 74th Behavioral Healthcare (BHC) transaction of the year and 21st BHC acquisition of Q3:22.
Founded in 2014, BrightView Health operates 64 locations in Ohio, Delaware, Kentucky, Virginia, North Carolina, Connecticut and Massachusetts. BrightView’s substance abuse treatment programs focus on meth addiction, heroin addiction, opioid addiction as well as Suboxone and Vivitrol treatment.
Corebella Health & Wellness has locations in Tempe, Glendale and Scottsdale, Arizona. It was founded in 2015 and specializes in the treatment of attention-deficit hyperactivity disorder, bipolar disorder, pain management and addiction medicine, including alcohol dependence, substance abuse, fentanyl and heroin addiction. It employs 25 people.
Once the acquisition is finalized, Corebella will operate under the BrightView name. Corebella Health is BrightView’s third acquisition of 2022 and its ninth deal since 2020. This is also Shore Capital Partners’ fourth acquisition in the BHC market this year.
According to the LevinPro HC database, the disclosed purchase prices of BHC deals total more than $2.245 billion in 2022. The deal with the largest purchase price is Charlesbank Capital Partners purchasing Action Behavior Centers for $840 million. Through its portfolio companies, BayMark Health Services and Discovery Behavioral Health, PE group Webster Equity Partners has made the most BHC acquisitions this year with four transactions. None of the prices were disclosed.
